- Home
- GSHD vs MNKD Comparison
GSHD vs MNKD Comparison
Compare GSHD & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSHD | MNKD |
|---|---|---|
| Founded | 2003 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | GSHD | MNKD |
|---|---|---|
| Price | $71.62 | $5.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $95.73 | $10.08 |
| AVG Volume (30 Days) | 235.8K | ★ 3.9M |
| Earning Date | 02-23-2026 | 02-25-2026 |
| Dividend Yield | ★ 8.26% | N/A |
| EPS Growth | ★ 68.12 | 23.47 |
| EPS | ★ 1.14 | 0.10 |
| Revenue | ★ $353,231,000.00 | $313,787,000.00 |
| Revenue This Year | $16.89 | $21.40 |
| Revenue Next Year | $18.89 | $25.03 |
| P/E Ratio | $63.00 | ★ $53.22 |
| Revenue Growth | ★ 25.01 | 17.43 |
| 52 Week Low | $64.41 | $3.38 |
| 52 Week High | $127.99 | $6.51 |
Technical Indicators
Market Signals| Indicator | GSHD | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 44.22 | 33.22 |
| Support Level | $69.84 | $5.53 |
| Resistance Level | $74.12 | $5.68 |
| Average True Range (ATR) | 3.01 | 0.22 |
| MACD | -0.35 | -0.06 |
| Stochastic Oscillator | 29.83 | 4.55 |
Price Performance
Historical ComparisonAbout GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.